Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2012
12/26/2012CN102258492B Neostigmine bromide slow release preparation and its preparation method
12/26/2012CN102247500B External use medicinal ointment for treating anorectal diseases and preparation method thereof
12/26/2012CN102228616B Chinese patent medicine for treating digestive system disease
12/26/2012CN102218132B Medicinal composition for treating nasal bleeding
12/26/2012CN102205085B Anti-ulcer powder for treating stomach disease
12/26/2012CN102205068B Medicament for treating chronic ulcerative colitis and preparation method thereof
12/26/2012CN102188523B Plant antibiotic
12/26/2012CN102138939B Preparation method of asterias amurensis polysaccharide extract and medical applications thereof
12/26/2012CN102119927B Enteric-coated pellet preparation of proton pump inhibitor and preparation method thereof
12/26/2012CN102078028B Cigarette for benefiting gallbladder, reducing blood pressure and giving up smoking and preparation method thereof
12/26/2012CN102048753B Preparation method and applications of Tibetan medical decoction iron powder
12/26/2012CN102038939B Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection
12/26/2012CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method
12/26/2012CN101972220B Medicated toothpaste
12/26/2012CN101953773B Lamivudine liposome solid preparation
12/26/2012CN101863985B Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
12/26/2012CN101844970B Dibenzocyclooctene lignin derivatives with bioactivity
12/26/2012CN101835478B Laxative agent
12/26/2012CN101804047B Antimicrobial and radioprotective compounds
12/26/2012CN101780246B Traditional Chinese medicine composition with function of promoting digestion and preparation method thereof
12/26/2012CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof
12/26/2012CN101439181B Stable water injection medicament composition containing Ulinastatin
12/26/2012CN101437799B p38 MAP kinase inhibitors
12/26/2012CN101258143B 苄基哌嗪衍生物及其医学用途 Benzyl piperazine derivatives and their medical use
12/26/2012CN101076521B Process for producing muscarine receptor antagonist and intermediate therefor
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338478 Derivatives of 3,3-diphenylpropylamines
12/25/2012US8338385 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/25/2012US8337889 Smectite dispersible tablets and the preparation thereof
12/25/2012US8337886 Pellet formulation for the treatment of the intestinal tract
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/20/2012WO2012174253A1 Methods for aloe processing
12/20/2012WO2012173464A1 Oral care product for oral hygiene and growth inhibition of microorganisms
12/20/2012WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
12/20/2012WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes
12/20/2012WO2012172635A1 Method for producing anticariogenic composition
12/20/2012WO2012171621A1 Pharmaceutical preparation for treating infections of the intestine with ehec bacteria
12/20/2012WO2012171334A1 Method for transdifferentiating fibroblast into liver stem cell
12/20/2012WO2012171077A1 Method and composition for treatment or inhibition of mucositis associated with chemotherapy or radiation damage
12/20/2012WO2012105798A3 Composition containing chlorogenic acid for preventing or treating gastroesophageal reflux disease
12/20/2012US20120322854 Regulation of macrophage activation using mir-125b
12/20/2012US20120322853 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/20/2012US20120322851 Oral delivery of therapeutically effective lna oligonucleotides
12/20/2012US20120322843 Genotype specific methods for treating human subjects using 4-methylpyrazole
12/20/2012US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/20/2012US20120322837 Amide compound and medicinal use thereof
12/20/2012US20120322822 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322814 Methods of inhibiting ire1
12/20/2012US20120322809 Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322793 Protein kinase inhibitors
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322773 Materials and methods for treatment of disorders associated with oxidative stress
12/20/2012US20120322757 Methods for Aloe Processing
12/20/2012US20120322754 Novel use for scopolin and derivatives thereof
12/20/2012US20120322740 Mu opioid receptor agonist analogs of the endomorphins
12/20/2012US20120322729 High activity growth factor mutants
12/20/2012US20120322723 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa
12/20/2012US20120322719 Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321702 Pharmaceutical composition of lansoprazole
12/20/2012US20120321693 Prg4 treatment for interstitial cystitis
12/20/2012US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321629 Stem cell factor inhibitor
12/20/2012US20120321600 Infant formula with probiotics and milk fat globule membrane components
12/20/2012US20120321556 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
12/20/2012US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
12/20/2012CA2841416A1 Method of selecting therapeutic indications
12/19/2012EP2535413A2 Splice switching oligomers for the TNF superfamily receptors and their use in treatment of disease
12/19/2012EP2535330A2 Iminopyridine derivative and use thereof
12/19/2012EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
12/19/2012EP2533803A1 Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases
12/19/2012EP2533801A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention
12/19/2012EP2533794A1 Protein domains and uses therefor
12/19/2012EP2533786A2 Methods and compositions to improve mechanical resistance of teeth
12/19/2012CN202605099U Moxibustion paster
12/19/2012CN102827737A Health-care wine for clearing liver and improving eyesight
12/19/2012CN102827735A Health-care wine for enriching blood, relaxing bowel, reducing phlegm and depressing blood-fat
12/19/2012CN102827288A Acid-activated CSP targeted antimicrobial peptide and preparation method and applications thereof
12/19/2012CN102827280A Anti-IL-13 antibodies and use thereof
12/19/2012CN102827269A Thymulin alpha 1 analog and preparation method thereof
12/19/2012CN102827265A Novel gene of sorting nexin (SNX) family and use thereof
12/19/2012CN102827257A Peptide fragment of gp96 protein and applications thereof
12/19/2012CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof
12/19/2012CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof
12/19/2012CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof
12/19/2012CN102827227A Silicon phthalocyanine modified by adenosine derivative and preparation method and application thereof
12/19/2012CN102827226A Silicon phthalocyanine modified by uridine derivatives and preparation method and application of silicon phthalocyanine
12/19/2012CN102827206A Pradefovir crystal
12/19/2012CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor
12/19/2012CN102827147A Omeprazole sodium crystal compound and medicine composition containing omeprazole sodium crystal compound
12/19/2012CN102827001A Ilex kudingcha C.J.Tseng extract
12/19/2012CN102826752A Bioactive mineral powder containing quasi-nanometer?particles, preparation method and application thereof in dental treatment
12/19/2012CN102824646A Conjugate of polyethylene glycol interferon